These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10414466)

  • 1. Granulocyte/macrophage-colony-stimulating factor released by adenovirally transduced CT26 cells leads to the local expression of macrophage inflammatory protein 1alpha and accumulation of dendritic cells at vaccination sites in vivo.
    Kielian T; Nagai E; Ikubo A; Rasmussen CA; Suzuki T
    Cancer Immunol Immunother; 1999; 48(2-3):123-31. PubMed ID: 10414466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice.
    Nagai E; Ogawa T; Kielian T; Ikubo A; Suzuki T
    Cancer Immunol Immunother; 1998 Oct; 47(2):72-80. PubMed ID: 9769115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL3/MIP-1alpha is a potent immunostimulator when coexpressed with interleukin-2 or granulocyte-macrophage colony-stimulating factor in a leukemia/lymphoma vaccine.
    Zibert A; Balzer S; Souquet M; Quang TH; Paris-Scholz C; Roskrow M; Dilloo D
    Hum Gene Ther; 2004 Jan; 15(1):21-34. PubMed ID: 14965375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity.
    Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H
    Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocyte-macrophage colony-stimulating factor in human colon cancer cells.
    Shinohara H; Yano S; Bucana CD; Fidler IJ
    J Immunol; 2000 Mar; 164(5):2728-37. PubMed ID: 10679114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model.
    Herrlinger U; Aulwurm S; Strik H; Weit S; Naumann U; Weller M
    J Neurooncol; 2004 Jan; 66(1-2):147-54. PubMed ID: 15015780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine and chemokine receptor expression by liver-derived dendritic cells: MIP-1alpha production is induced by bacterial lipopolysaccharide and interaction with allogeneic T cells.
    Drakes ML; Zahorchak AF; Takayama T; Lu L; Thomson AW
    Transpl Immunol; 2000 Mar; 8(1):17-29. PubMed ID: 10834607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG-independent synergistic induction of beta-chemokines and a dendritic cell phenotype by orthophosphorothioate oligodeoxynucleotides and granulocyte-macrophage colony-stimulating factor in elutriated human primary monocytes.
    Wang J; Alvarez R; Roderiquez G; Guan E; Caldwell Q; Wang J; Phelan M; Norcross MA
    J Immunol; 2005 May; 174(10):6113-21. PubMed ID: 15879106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.
    Inoue H; Iga M; Nabeta H; Yokoo T; Suehiro Y; Okano S; Inoue M; Kinoh H; Katagiri T; Takayama K; Yonemitsu Y; Hasegawa M; Nakamura Y; Nakanishi Y; Tani K
    Cancer Sci; 2008 Nov; 99(11):2315-26. PubMed ID: 18957055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection.
    Gonzalez-Juarrero M; Hattle JM; Izzo A; Junqueira-Kipnis AP; Shim TS; Trapnell BC; Cooper AM; Orme IM
    J Leukoc Biol; 2005 Jun; 77(6):914-22. PubMed ID: 15767289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene.
    Kusumoto M; Umeda S; Ikubo A; Aoki Y; Tawfik O; Oben R; Williamson S; Jewell W; Suzuki T
    Cancer Immunol Immunother; 2001 Sep; 50(7):373-81. PubMed ID: 11676397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies.
    Nelson WG; Simons JW; Mikhak B; Chang JF; DeMarzo AM; Carducci MA; Kim M; Weber CE; Baccala AA; Goeman MA; Clift SM; Ando DG; Levitsky HI; Cohen LK; Sanda MG; Mulligan RC; Partin AW; Carter HB; Piantadosi S; Marshall FF
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S67-72. PubMed ID: 10950151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor.
    Wang XY; Li Y; Manjili MH; Repasky EA; Pardoll DM; Subjeck JR
    Cancer Immunol Immunother; 2002 Aug; 51(6):311-9. PubMed ID: 12111119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
    Soiffer R; Hodi FS; Haluska F; Jung K; Gillessen S; Singer S; Tanabe K; Duda R; Mentzer S; Jaklitsch M; Bueno R; Clift S; Hardy S; Neuberg D; Mulligan R; Webb I; Mihm M; Dranoff G
    J Clin Oncol; 2003 Sep; 21(17):3343-50. PubMed ID: 12947071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity.
    Sun Y; Peng D; Lecanda J; Schmitz V; Barajas M; Qian C; Prieto J
    Gene Ther; 2000 Sep; 7(17):1467-76. PubMed ID: 11001366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte macrophage colony-stimulating factor and interleukin-3 regulate chemokine and chemokine receptor expression in bone marrow macrophages.
    Jarmin DI; Nibbs RJ; Jamieson T; de Bono JS; Graham GJ
    Exp Hematol; 1999 Dec; 27(12):1735-45. PubMed ID: 10641591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Ishida K; Primus FJ; Yamaue H
    Int J Cancer; 2007 Feb; 120(3):585-93. PubMed ID: 17096339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local and systemic effects after adenoviral transfer of the murine granulocyte-macrophage colony-stimulating factor gene into mice.
    Burger JA; Baird SM; Powell HC; Sharma S; Eling DJ; Kipps TJ
    Br J Haematol; 2000 Mar; 108(3):641-52. PubMed ID: 10759724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.